Search Results
Aug 10, 2026, 10:07 ET Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky
Services' Top 50 Report.Frequently Asked Questions About the MYGN Investigation Q: What is the MYGN securities investigation about? A: A securities investigation is pending concerning Myriad Genetics (NASDAQ: MYGN) regarding potentially materially false or misleading statements. Shares
More news about: Levi & Korsinsky
Aug 04, 2026, 10:07 ET MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics
eligible to participate in the MYGN investigation? A: Investors who purchased MYGN stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares. Q: What do MYGN investors need to do right
More news about: SueWallSt.com
Aug 03, 2026, 18:14 ET Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)
participate in the MYGN investigation? A: Investors who purchased MYGN stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares. Q: Who is conducting the MYGN investigation?
More news about: Levi & Korsinsky, LLP
Mar 06, 2026, 18:39 ET Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
Myriad Genetics MYGNHealth Care
More news about: S&P Dow Jones Indices
Sep 23, 2025, 08:01 ET Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and
More news about: SOPHiA GENETICS
Sep 23, 2025, 08:01 ET Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and
More news about: SOPHiA GENETICS